FindTrial
Sign In

Comparison of high flow nasal cannula and non invasive ventilation in transport of critically ill patients in hospital

Intrahospital transport of critically ill patients using high flow nasal cannula or non invasive ventilation: A randomised comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054931
Enrollment
50
Registered
2023-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system

Interventions

Intervention1: High flow nasal cannula (HFNC)/ non invasive ventilation (NIV): Total duration- 18 months Patients will be randomized to HFNC or NIV groups. Group I (intervention) (non-invasive venti

Sponsors

Eras Lucknow Medical College and Hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age 18 years or above 2) Critically ill patients requiring intra- hospital transport

Exclusion criteria

Exclusion criteria: 1) Severe respiratory failure requiring immediate tracheal intubation (respiratory frequency 40 times/min, severe hypoxia, severe respiratory acidosis with a ph 2) A contraindication to NIV (oral and facial trauma, excessive phlegm with poor expectoration ability, hemodynamic instability). 3) Patients with poor short term prognosis (very high risk of death within seven days or receiving palliative care). 4) Pregnant women. 5) Carriers of an implantable defibrillator or pacemaker. 6) Tracheostomized patients.

Design outcomes

Primary

MeasureTime frame
1) To determine the effect on oxygenation, by measuring SpO2 during transportation. 2) To determine the need to escalate/de-escalate respiratory support/ invasive mechanical ventilation after ICU admission. Timepoint: 1) during tansportation of patient 2) 5 minutes, 15 minutes, 1 hour, 24 hours, 48 hours after transport.—

Secondary

MeasureTime frame
to record: 1.duration of respiratory support. 2.adverse events during transportation. 3.length of icu stay. 4.length of hospital stay. 5.icu mortality. 6.hospital mortality.Timepoint: 72 hours after transport, 7 days after transport—

Countries

India

Contacts

Public ContactDr Raydhi Sharma

Eras Lucknow Medical College and Hospita

genesishealthcare121@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026